Efficacy of an EGFR-Specific Peptide against EGFR-Dependent Cancer Cell Lines and Tumor Xenografts

We have recently synthesized a peptide called Disruptin, which comprised the SVDNPHVC segment of the epidermal growth factor receptor (EGFR) that inhibits binding of heat shock protein 90 (Hsp90) to the EGFR and EGF-dependent EGFR dimerization to cause EGFR degradation. The effect is specific for EG...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
Main Authors: Ahsan, Aarif, Ramanand, Susmita G, Bergin, Ingrid L, Zhao, Lilli, Whitehead, Christopher E, Rehemtulla, Alnawaz, Ray, Dipankar, Pratt, William B, Lawrence, Theodore S, Nyati, Mukesh K
פורמט: Artigo
שפה:Inglês
יצא לאור: Neoplasia Press Inc. 2014
נושאים:
Research Article
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC3978391/
https://ncbi.nlm.nih.gov/pubmed/24709418
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים